University of Freiburg
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1457-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uni-freiburg.de
BrainCool Expands COTTIS 2 Trial for Stroke Hypothermia Treatment
• BrainCool AB adds two German hospitals to its COTTIS 2 clinical study, aiming to evaluate hypothermic treatment for ischemic stroke patients.
• The COTTIS 2 trial will assess the combination of RhinoChill® and BrainCool™ systems with thrombectomy in 400 patients with large vessel occlusion.
• The study seeks to gather clinical data supporting market approval for RhinoChill® as a hypothermic treatment for ischemic stroke.
• Interim analyses are planned to document the benefits of combined treatment, with the goal of accelerating patient inclusion in 2025.
© Copyright 2025. All Rights Reserved by MedPath